Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$2,833,986.00
Oct 6, 2020
For-profit organization
815966
815966
The project is to undertake the commercialization and manufacturing of sample preparation kits and test cartridges that accompany the Spartan Cube Covid-19 testing system.
$2,833,986.00
Oct 6, 2020
For-profit organization
815966
815966
The project is to support Spartan Bioscience Inc. scale-up and manufacture their medical testing device.
$75,000.00
Jul 1, 2020
For-profit organization
Entering European Markets with Spartan’s Medical Platform: rapid CYP2C19 testing and portable COVID19 testing
953830
To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.
$687,928.00
Mar 23, 2020
For-profit organization
COVID-19 Test Development
947397
Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample collection. The portable size of the Cube, along with the simplicity of the proposed workflow allows the solution to be deployed and implemented into airports, border crossings, and critical national infrastructure with ease.
$150,000.00
Mar 6, 2020
For-profit organization
1920-HQ-000294
1920-HQ-000294
Not a Project (Mandated or Core Funding)
$74,625.00
Oct 2, 2019
For-profit organization
Creating international markets for on-site Legionella DNA testing
936000
Spartan has created the first on-site Legionella DNA test to prevent Legionnaires’ disease outbreaks. This project will enable Spartan to build on our initial success in North America and export the test to a key export markets.
$349,000.00
Aug 1, 2018
For-profit organization
Temperature-stable DNA test cartridges for Legionella
912168
Spartan Bioscience has developed the world’s first on-site Legionella DNA test to prevent Legionnaires’ disease outbreaks. This project will enable Spartan to develop room-temperature stable cartridges to improve shelf life and shipping requirements.
$30,000.00
Nov 30, 2017
$30,000.00
Nov 13, 2017
For-profit organization
YOUTH: Legionella Detection System user interface
897592
The project involves human factors testing of a new user interface for Spartan's Legionella Detection System.
$25,000.00
Aug 23, 2017
Engagement with Spartan: exploring organic thin film transistors for DNA sensor
EGP